17 completed, 14 unknown, 3 terminated, 2 recruiting. 30 Phase 2, 6 Phase 1, 6 Phase 3, 1 Not applicable, 1 Phase 4.
Follow Danazol: new trials by email Literature Review of Danazol trials Research Report on Danazol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia Thalidomide, Danazol, Prednisolone - Beta-Thalassemia, Thalassemia | Phase 3 | Recruiting | Khyber Medical University Peshawar | 172 | 2026-10-12 | 2026-10-21 |
| Danazol for Treatment of Cytopenias in Patients With Cirrhosis Danazol Pill - Cirrhosis, Liver, Cytopenia | Phase 2 | Recruiting | University of Southern California | 10 | 2024-08-01 | 2025-07-11 |
| The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia Teriflunomide, Danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 124 | 2023-12-05 | 2023-12-20 |
| Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia Baricitinib 2 MG [Olumiant], Danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 216 | 2023-05-16 | 2023-06-13 |
| Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis Dienogest, Danazol - Endometriosis | Phase 3 | Unknown | Far Eastern Memorial Hospital | 120 | 2023-02-25 | 2023-03-29 |
| The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia Terbutaline, Danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 228 | 2022-09-01 | 2022-08-09 |
| The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia TAC, Danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2022-03-02 | 2022-07-22 |
| Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol - Myelodysplastic Syndromes (MDS) | Phase 2 | Unknown | Prof. Janet Dunn | 120 | 2021-12-21 | 2023-10-03 |
| The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis Danazol, Placebo - Pulmonary Fibrosis, Telomere Shortening | Phase 2 | Terminated | The University of Queensland | 29 | 2021-09-07 | 2025-08-05 |
| The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Iguratimod, Danazol - ITP, Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-09-01 | 2022-05-02 |
| The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Sitagliptin, Danazol - Immune Thrombocytopenia, Blood Coagulation Disorders | Phase 2 | Unknown | Peking University People's Hospital | 120 | 2021-06-01 | 2022-04-29 |
| PRETELL: PREvention of TELomere-related Complications After Lung Transplant Danazol Pill, Placebo - Short Telomere Length, Lung Transplant | Phase 1 / Phase 2 | Withdrawn | Brigham and Women's Hospital | 2021-01-01 | 2023-02-15 | |
| Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers. Bupropion, Anastrozole, Testosterone cyclopentylpropionate - Healthy Volunteers | Phase 1 | Completed | Parc de Salut Mar | 9 | 2020-12-03 | 2021-04-26 |
| The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Terbutaline, Danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 40 | 2020-07-08 | 2020-07-22 |
| A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia Danazol + rhTPO (recombinant human thrombopoietin injection), Danazol + sodium chloride - Low/Intermediate Risk-1 MDS | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 75 | 2020-03-01 | 2020-03-27 |
| Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia Romiplostim and danazol - Immune Thrombocytopenia | Phase 2 | Unknown | Seoul National University Hospital | 55 | 2020-03-01 | 2020-02-28 |
| A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) Momelotinib, Placebo to match danazol, Danazol - Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 3 | Completed | Sierra Oncology LLC - a GSK company | 195 | 2020-02-07 | 2023-11-01 |
| Effects of Telomerase Reactivation With Danazol in Ovarian Function. Danazol/Placebo, Without intervention - Ovarian Reserve | Not applicable | Completed | IVI Madrid | 19 | 2020-01-30 | 2022-08-10 |
| Letrozole vs Danazol for Endometriosis-Related Pain: Randomized Trial Letrozole, danazol - Endometriosis | Phase 2 | Completed | Sidra Salman | 60 | 2019-04-10 | 2025-09-19 |
| Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy Danazol 200 MG - Telomere Shortening, Telomere Length, Mean Leukocyte | Phase 1 / Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 40 | 2018-10-20 | 2018-10-18 |
Showing 20 of 38. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (11) · Endometriosis (4) · Anemia (3) · Liver Cirrhosis (3) · Primary Myelofibrosis (3) · Pulmonary Fibrosis (3) · Anemia, Aplastic (2) · Bone Marrow Diseases (2) · Dyskeratosis Congenita (2) · Fibrocystic Breast Disease (2) · Hematologic Diseases (2) · Macular Edema (2) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cytopenia (1)
Peking University People's Hospital (10) · FemmePharma Global Healthcare, Inc. (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Ain Shams University (1) · Ampio Pharmaceuticals. Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · Boston Children's Hospital (1) · Brigham and Women's Hospital (1) · Centre for Endocrinology and Reproductive Medicine, Italy (1) · Far Eastern Memorial Hospital (1) · Gynecologic Oncology Group (1) · IVI Madrid (1) · Icahn School of Medicine at Mount Sinai (1) · Khyber Medical University Peshawar (1) · Mayo Clinic (1)
United States (12) · China (10) · Italy (4) · Spain (4) · Australia (3) · Canada (3) · United Kingdom (3) · Bulgaria (2) · Czechia (2) · France (2) · Hungary (2) · Israel (2) · Pakistan (2) · Poland (2) · Romania (2)
Xiao-Hui Zhang, MD (4) · Xiaohui Zhang, MD (3) · Ruben Mesa (2) · Allan Covens, MD (1) · Ana M Aldea Perona, MD PhD (1) · Brian M. Berman, MD (1) · Casey O'Connell, MD (1) · Colin A Sieff, MB.BCh (1) · Emma M Groarke, M.D. (1) · Gulab Fatima Rani, MBBS, PhD (1) · Howard Levy, M.D. (1) · Ilan Shapira, M.D. (1) · Marco Sbracia, MD (1) · Mohamed Samy, MD (1)
PMID 12798713, PMID 17462175, PMID 26099553, PMID 27192671, PMID 27864867, PMID 28917657, PMID 33232476, PMID 34778037, PMID 34857525, PMID 36709073, PMID 37042865, PMID 37517413, PMID 39516087, PMID 40535755, PMID 40691344, PMID 41958363, PMID 42316774, PMID 42452788, PMID 42649137
2018 (1), P30CA015083 (1), U19AT003266 (1)